TRIM26 may directly interact with ETK and enhance its ubiquitination, hence deactivating the AKT/mTOR signaling pathway in ccRCC and impeding the development of ccRCC. This evidence concerns the gene TRIM26 and nonpapillary renal cell carcinoma.